Annual Drug Patent Expirations for FIRVANQ+KIT
Firvanq Kit is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has seven patent family members in six countries.
The generic ingredient in FIRVANQ KIT is vancomycin hydrochloride. One supplier is listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com